| 1 |
Zohaib Mahmood |
Nanosemi |
10 |
| 2 |
Dwight Meglan |
Covidien Lp |
6 |
| 2 |
William Querbes |
Alnylam Pharmaceuticals |
6 |
| #4 |
Evan James White |
Sharkninja Operating |
3 |
| #4 |
Matthew T. Sullivan |
Schlumberger Technology |
3 |
| #4 |
Joey L. Methot |
Merck |
3 |
| #4 |
Carolina Lucchesi |
Emulate |
3 |
| #4 |
Daniel R. DER MARDEROSIAN |
Sharkninja Operating |
3 |
| #4 |
James Aggen |
Achaogen |
3 |
| #4 |
Bingsong Han |
Forma Therapeutics |
3 |
| #4 |
Nickolay Lapin |
Portal Instruments |
3 |
| #4 |
Youzhi Li |
Covidien Lp |
3 |
| #4 |
Xiaodong Tao |
GE |
3 |
| #14 |
Roy Lobb |
Biogen |
2 |
| #14 |
Yihao Zheng |
University of Michigan |
2 |
| #14 |
Magali B. Hickey |
Alkermes Pharma Ireland Limited |
2 |
| #14 |
Kenneth W. Duncan |
Epizyme |
2 |
| #14 |
Nelson Ruiz-Opazo |
Boston University |
2 |
| #19 |
David Eric Abramowitz |
— |
1 |
| #19 |
Marco G. Catalani |
Microfluidics International |
1 |
| #19 |
Francis Campion |
IBM |
1 |
| #19 |
William McInnis |
Reebok International Limited |
1 |
| #19 |
Ronald N. Reece |
Axcelis Technologies |
1 |
| #19 |
Carol Lucchesi |
Emulate |
1 |
| #19 |
Scott J. Rodig |
Dana-Farber Cancer Institute |
1 |
| #19 |
Matthew J. Greenway |
Bose |
1 |
| #19 |
Katariina Lahti |
Alcon Research |
1 |
| #19 |
Chetan Gopal |
Avocado Systems |
1 |
| #19 |
Matthew D. Powell |
— |
1 |
| #19 |
Neal Doyle |
— |
1 |
| #19 |
Mark Alan Bates |
Zoox |
1 |
| #19 |
Robert F. Praino, Jr. |
Qd Vision |
1 |
| #19 |
Dhruv Kam Sethi |
Obsidian Therapeutics |
1 |
| #19 |
Ilias Levis |
Alcon Research |
1 |
| #19 |
John L. Clare |
— |
1 |
| #19 |
Richard WARBURG |
— |
1 |
| #19 |
Stan Zdonik |
Tamr |
1 |
| #19 |
Anthony Gelsomini |
Zscaler |
1 |
| #19 |
Jocemar Ramina |
Microfluidics International |
1 |
| #19 |
Edward Driscoll |
Data General |
1 |
| #19 |
Adam R. Spirer |
Analog Devices |
1 |
| #19 |
Andrei Bezdedeanu |
— |
1 |
| #19 |
Robert Rich |
Reebok International Limited |
1 |
| #19 |
Peter T. Frodigh |
— |
1 |